ECB President Lagarde (Q&A) says there is a range of data ECB will be monitoring in the coming weeks; again notes uncertainties

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

US FDA proposes to exclude Semaglutide (NOVOB DC), Tirzepatide (LLY), and Liraglutide (NOVOB DC) on 503B bulks list

ECB President Lagarde (Q&A) says directionally, she knows where the ECB is heading, but again notes the uncertainty, and says it remains to be seen

ECB President Lagarde (Q&A) says there is a range of data ECB will be monitoring in the coming weeks; again notes uncertainties

ECB President Lagarde (Q&A) says GC wants to stay away from the risks of being too early, and the risks of being too late

Iranian MP Mottaki tells Tasnim "We have no concerns about the Iranian negotiating team headed by Ghalibaf"

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

Lagarde's comments highlight the ECB's cautious stance as it evaluates incoming data amidst ongoing uncertainties. This suggests a potentially more data-dependent approach to future monetary policy decisions, which could impact market expectations for interest rates and the euro. Traders should watch for further developments in economic indicators that may influence the ECB's policy trajectory.

Related headlines

The feed had this first.

Use the Platform